Skip to main content
Smart Investors Daily
YI

NASDAQ · YI

111, Inc.

Healthcare · Medical - Pharmaceuticals

$2.79

Down-$0.28 (-9.99%)

Updated Nov 20, 2026, 1:07 AM

SID Score

3.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
33.2M
P/E ratio
-3.16
Dividend yield
0.00%
52-week range
$2.48 – $11.17
Volume
348.26
Avg. volume
16.3K

Price performance · YI

YI price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

YI closed at $2.79 after 20 trading sessions, down 9.17% for the selected period.

Last close
$2.79
Period change
-9.17%
Period low
$2.77
Period high
$3.07
Daily close
View OHLC price history
YI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$2.7885$2.7885$2.7885$2.7885348.26
Nov 17, 2026$2.85$2.85$2.7294$2.7681.33K
Nov 16, 2026$2.85$2.90$2.7237$2.843.63K
Nov 13, 2026$2.87$2.93$2.84$2.844.26K
Nov 12, 2026$2.82$2.90$2.789$2.8514.93K
Nov 11, 2026$2.9359$2.9359$2.86$2.929710.58K
Nov 10, 2026$2.95$2.96$2.95$2.954.94K
Nov 9, 2026$2.92$2.929$2.92$2.929728.73
Nov 6, 2026$2.95$2.95$2.90$2.9056.91K
Nov 5, 2026$3.05$3.07$2.95$2.9832.82K
Nov 4, 2026$3.05$3.05$3.00$3.008.3K
Nov 3, 2026$3.03$3.05$2.995$3.024.12K
Nov 2, 2026$2.86$3.02$2.83$2.923.07K
Oct 30, 2026$2.935$2.935$2.85$2.8521.64K
Oct 29, 2026$2.96$3.09$2.76$2.98100.41K
Oct 28, 2026$2.94$3.1229$2.94$2.975.41K
Oct 27, 2026$2.95$3.075$2.915$3.0016.19K
Oct 26, 2026$3.00$3.1197$2.96$3.0011.34K
Oct 23, 2026$3.05$3.08$2.85$2.8615.23K
Oct 22, 2026$3.15$3.18$3.07$3.0714.4K

Latest YI news

The latest Smart Investors Daily articles mentioning YI.

YI research

Overview

Company profile and research snapshot.

Company profile

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

defenseworld.net · Nov 27, 2025

Head to Head Contrast: Privia Health Group (NASDAQ:PRVA) & 111 (NASDAQ:YI)

Privia Health Group (NASDAQ: PRVA - Get Free Report) and 111 (NASDAQ: YI - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Institutional and Insider Ownership 94.5% of Privia Health

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.